Stocks and InvestingStocks and Investing
Thu, March 10, 2022
Wed, March 9, 2022
Tue, March 8, 2022
Mon, March 7, 2022

Brian Tanquilut Maintained (THC) at Strong Buy with Increased Target to $125 on, Mar 7th, 2022


Published on 2024-10-27 19:59:17 - WOPRAI, Brian Tanquilut
  Print publication without navigation


Brian Tanquilut of Jefferies, Maintained "Tenet Healthcare Corporation" (THC) at Strong Buy with Increased Target from $120 to $125 on, Mar 7th, 2022.

Brian has made no other calls on THC in the last 4 months.



There are 10 other peers that have a rating on THC. Out of the 10 peers that are also analyzing THC, 1 agrees with Brian's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Scott Fidel of "Stephens & Co." Maintained at Hold with Increased Target to $92 on, Tuesday, November 9th, 2021


These are the ratings of the 9 analyists that currently disagree with Brian


  • Ann Hynes of "Mizuho" Maintained at Strong Buy with Increased Target to $103 on, Thursday, March 3rd, 2022
  • Jamie Perse of "Goldman Sachs" Initiated at Strong Buy on, Tuesday, March 1st, 2022
  • Andrew Mok of "UBS" Upgraded from Hold to Strong Buy and Increased Target to $111 on, Thursday, February 10th, 2022
  • A.J. Rice of "Credit Suisse" Maintained at Buy with Increased Target to $111 on, Wednesday, February 9th, 2022
  • David Macdonald of "Truist Securities" Upgraded from Hold to Strong Buy and Held Target at $90 on, Wednesday, February 9th, 2022
  • Pito Chickering of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $100 on, Wednesday, February 9th, 2022
  • Sarah James of "Barclays" Maintained at Buy with Increased Target to $99 on, Wednesday, February 9th, 2022
  • Whit Mayo of "SVB Leerink" Upgraded from Hold to Buy and Increased Target to $100 on, Wednesday, February 9th, 2022
  • John Ransom of "Raymond James" Upgraded from Buy to Strong Buy and Increased Target to $120 on, Thursday, January 20th, 2022